Anthropic's Secretive AI-Powered Wet Lab Breaks Cover and Makes First Discovery (www.the-scientist.com)

Anthropic, a prominent player in AI, has officially launched a human-staffed wet lab in the San Francisco Bay Area, marking its expansion into life sciences. This facility, operational since spring 2023, has already made a significant discovery: a novel enzyme system with characteristics akin to CRISPR, developed through its bioinformatics platform, Claude Science. This venture aims to tackle “undruggable” conditions in biology, using AI to analyze DNA sequences linked to lesser-understood proteins, while maintaining a human-first approach for actual lab work. The lab's standout achievement, termed array-associated reverse transcriptases (ART), emerged from a day-long AI-driven analysis involving 950 agents that sifted through a vast database. It identified a previously overlooked element—a tandem repeat array critical for CRISPR-like action—within a recognized RNA-writing RT enzyme. This innovative use of AI underscores the potential of machine learning to accelerate biological discovery and contribute meaningfully to the field. Despite Anthropic's emphasis on not competing with traditional pharma, the implications for research accessibility and collaboration raise critical questions about the integration of AI in life sciences, especially as it generates powerful tools not readily available to external academics.